tiprankstipranks
Trending News
More News >
MDB Capital Holdings, LLC Class A (MDBH)
NASDAQ:MDBH
US Market

MDB Capital Holdings, LLC Class A (MDBH) AI Stock Analysis

Compare
15 Followers

Top Page

MDBH

MDB Capital Holdings, LLC Class A

(NASDAQ:MDBH)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
$3.50
▼(-0.57% Downside)
MDBH scores in the upper-middle range primarily due to balance-sheet strength and a low P/E, but the overall rating is held back by weak cash generation, persistently negative gross profit and operating losses, and earnings-call risks tied to operating expense pressures and execution delays. Technically, the stock shows modest improving momentum but remains below its longer-term (200-day) trend.
Positive Factors
Balance-sheet strength
Very low leverage and a sizable equity base provide durable financial flexibility, allowing the firm to fund operations, seed portfolio companies, and absorb volatility without immediate refinancing. Improved ROE signals healthier capital returns, supporting resilience over the next several quarters.
Proven IPO track record
A long, successful track record of launching public companies creates a structural competitive advantage: repeatable processes, credibility with issuers and investors, and a network that supports deal flow and syndication. This institutional know-how underpins sustainable advisory and underwriting revenue.
Established pipeline and scaling plan
A multi-company late-stage pipeline and an explicit target to increase annual launches from ~1.5 to 3–5 creates a structural growth vector. If executed, higher deal throughput can generate recurring fee income, spread fixed costs, and improve operating leverage across the public-venture platform over 2–6 months.
Negative Factors
Weak cash generation
Persistent negative operating and free cash flow despite reported net income indicates earnings are not converting to cash. This structural cash-conversion weakness raises funding risk for operations and portfolio support, likely requiring ongoing financings or asset monetization to sustain growth initiatives.
Negative gross profit and operating losses
Deep negative gross margins and negative EBIT show core operations are unprofitable and scale is not yet achieved. Reliance on non-operating items to produce net income undermines earnings quality and suggests margins may not sustainably support operating expansion without structural cost reductions or higher recurring fee revenue.
Expense burden and execution delays
High operating spend relative to realized financing proceeds, plus noted delays in monetizing key assets, creates a persistent funding gap. Over multiple quarters this increases reliance on external financing, elevates dilution or leverage risk, and magnifies execution risk tied to timely launches and asset commercialization.

MDB Capital Holdings, LLC Class A (MDBH) vs. SPDR S&P 500 ETF (SPY)

MDB Capital Holdings, LLC Class A Business Overview & Revenue Model

Company DescriptionMDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.
How the Company Makes MoneyMDB Capital Holdings generates revenue through several key streams. Primarily, it earns fees from its investment management services, which include asset management fees based on the performance of the funds it manages. Additionally, the company may receive success fees or commissions from advisory services provided to startups and established firms within its focus sectors. MDBH also potentially benefits from equity stakes in the companies it advises or invests in, allowing it to profit from successful exits or public offerings. Partnerships with technology firms and biotech companies further enhance its revenue potential by creating opportunities for co-investment and joint ventures.

MDB Capital Holdings, LLC Class A Earnings Call Summary

Earnings Call Date:Nov 20, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Apr 22, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted MDB Capital Holdings' successful track record in launching IPOs and scaling operations for future growth. However, significant challenges remain, including a declining stock price and a tough microcap market. Despite positive developments in their pipeline and upcoming launches, the operational expenses and delays in key projects temper the optimism.
Q3-2025 Updates
Positive Updates
Successful IPO Track Record
MDB Capital Holdings has launched numerous successful IPOs over 28 years, with 100% trading at 2x the IPO price at some point post-IPO.
Deep Pipeline of Opportunities
The company has a strong pipeline with 4 to 5 companies in late-stage negotiations, aiming for 3 to 5 launches next year.
eXoZymes and HeartBeam Developments
eXoZymes is expected to revolutionize pharmaceutical development, and HeartBeam is on the verge of FDA approval for a groundbreaking 12-lead ECG device.
Scaling Operations
MDB Capital Holdings aims to scale operations to launch 3 to 5 companies per year, supported by a proven operational framework.
Potential Spinout of PatentVest
Plans to spin out PatentVest, potentially the first public law firm in the U.S., focused on patent law.
Negative Updates
Stock Price Decline
MDB Capital Holdings' stock has declined significantly, trading at a discount despite existing equity positions exceeding market value.
Microcap Market Challenges
The microcap market has been challenging, with concerns about MDB's ability to pick successful ventures.
Operational Expenses
Operating expenses have yet to be fully offset by financings, with $5.9 million used in the first three quarters.
Delays in eXoZymes and Paulex Bio
Delays in monetizing eXoZymes and bringing Paulex Bio to market have been noted, impacting anticipated timelines.
Company Guidance
During the MDB Capital Holdings Third Quarter 2025 Update Conference Call, the company provided guidance emphasizing their strategy to scale operations by increasing the number of annual public venture launches from one every 18 months to three to five per year. CEO Chris Marlett highlighted MDB's plan to cover its $10 million operating expenses through financing activities while maintaining significant equity positions in launched companies, such as Paulex Bio and Buda Juice, to offer substantial shareholder value. Marlett expressed optimism about the potential resurgence of the microcap market, noting the scarcity of small public companies and the demand for public market liquidity. Additionally, MDB remains committed to delivering asymmetric returns by curating category-leading companies and positioning them for success in public markets. The company also aims to enhance investor relations efforts to better communicate the value of its portfolio and plans to leverage its unique public venture platform to capitalize on upcoming market opportunities.

MDB Capital Holdings, LLC Class A Financial Statement Overview

Summary
Strong balance sheet with very low leverage and improved ROE supports resilience, but fundamentals are mixed: gross profit remains deeply negative, operating losses persist (negative EBIT), and operating/free cash flow are negative despite positive net income—raising sustainability and cash-conversion concerns.
Income Statement
46
Neutral
Revenue accelerated sharply in TTM (Trailing-Twelve-Months) (up ~41%), but profitability quality is mixed. Gross profit remains deeply negative in both TTM and 2024, pointing to a cost structure that is not scaling well. Net income is positive in TTM and 2024 after losses in 2021–2023, but large operating losses (negative EBIT) suggest the bottom-line profitability is being driven by non-operating items rather than core operations, which reduces confidence in earnings sustainability.
Balance Sheet
78
Positive
The balance sheet is a clear strength: leverage is very low (debt-to-equity near zero in TTM and ~1% in 2024) with a sizable equity base relative to total assets. Return on equity is solidly positive in TTM and 2024 after being negative in 2021–2023, indicating improved shareholder returns. Key watch-out: equity declined from 2024 to TTM, so the direction of capital/base stability bears monitoring even with low debt.
Cash Flow
34
Negative
Cash generation is weak and volatile. Operating cash flow and free cash flow are negative in TTM and 2024 (and were also negative through most of 2021–2023), despite positive net income—suggesting earnings are not translating into cash. Free cash flow also deteriorated in TTM versus 2024, which raises funding and sustainability questions unless operating cash flow improves meaningfully.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.31M2.22M4.23M1.12M0.000.00
Gross Profit-8.72M-17.84M-4.39M-1.71M-1.97M-1.78M
EBITDA23.79M12.33M-9.76M-5.97M-5.67M-4.21M
Net Income11.43M11.69M-6.97M-5.31M-15.10M-722.18K
Balance Sheet
Total Assets61.51M71.98M42.99M25.70M8.25M27.94M
Cash, Cash Equivalents and Short-Term Investments15.93M20.44M6.11M4.95M6.23M12.48M
Total Debt635.42K711.50K2.42M1.42M720.63K251.34K
Total Liabilities1.88M1.90M5.67M2.59M1.49M3.33M
Stockholders Equity59.74M70.16M37.31M22.64M6.24M24.67M
Cash Flow
Free Cash Flow-4.13M-8.49M-7.60M-6.77M-6.26M9.44M
Operating Cash Flow-4.75M-9.04M-7.16M-6.57M-5.83M9.50M
Investing Cash Flow1.83M22.89M-8.20M-16.38M-423.39K-62.13K
Financing Cash Flow587.37K69.30K17.76M21.68M0.00250.96K

MDB Capital Holdings, LLC Class A Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.52
Price Trends
50DMA
3.42
Negative
100DMA
3.54
Negative
200DMA
3.84
Negative
Market Momentum
MACD
-0.04
Positive
RSI
40.79
Neutral
STOCH
16.15
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MDBH, the sentiment is Negative. The current price of 3.52 is above the 20-day moving average (MA) of 3.47, above the 50-day MA of 3.42, and below the 200-day MA of 3.84, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 40.79 is Neutral, neither overbought nor oversold. The STOCH value of 16.15 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MDBH.

MDB Capital Holdings, LLC Class A Risk Analysis

MDB Capital Holdings, LLC Class A disclosed 79 risk factors in its most recent earnings report. MDB Capital Holdings, LLC Class A reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

MDB Capital Holdings, LLC Class A Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$120.07M16.328.43%8.47%-32.22%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
63
Neutral
$38.05M7.869.56%6.45%214.07%-40.88%
61
Neutral
$63.43M0.71-29.28%
58
Neutral
$32.34M2.7725.75%121.21%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MDBH
MDB Capital Holdings, LLC Class A
3.19
-2.89
-47.53%
COHN
Cohen & Company
18.69
10.55
129.64%
SIEB
Siebert Financial
2.97
0.12
4.21%
DOMH
Dominari Holdings
3.91
1.05
36.71%
TOP
Zhong Yang Financial Group Ltd.
1.04
-0.34
-24.64%
GSIW
Garden Stage Ltd.
0.16
-0.31
-66.67%

MDB Capital Holdings, LLC Class A Corporate Events

Shareholder Meetings
MDB Capital Holds Successful Annual Stockholders Meeting
Positive
Dec 4, 2025

On December 2, 2025, MDB Capital Holdings, LLC held its Annual Meeting of Stockholders, where shareholders elected seven directors to serve until the 2026 meeting and ratified RBSM LLP as the independent accounting firm for the fiscal year ending December 31, 2025. The meeting saw a significant turnout, with 84.90% of eligible votes represented, and all proposals passed without broker non-votes, indicating strong shareholder support for the company’s governance and financial oversight decisions.

The most recent analyst rating on (MDBH) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on MDB Capital Holdings, LLC Class A stock, see the MDBH Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 14, 2026